US 12,096,784 B2
Protein compositions and consumable products thereof
Kritika Mahadevan, Daly City, CA (US); Joel Andrew Kreps, Daly City, CA (US); Isha Joshi, Daly City, CA (US); Farnoosh Ayoughi, Daly City, CA (US); Weixi Zhong, Daly City, CA (US); Harshal Kshirsagar, Daly City, CA (US); Alexandre Chapeaux, Daly City, CA (US); Wesley Rutherford-Jenkins, Daly City, CA (US); Ranjan Patnaik, Daly City, CA (US); Frank Douglas Ivey, Daly City, CA (US); Eric Lin, Daly City, CA (US); and Sridharan Govind, Daly City, CA (US)
Assigned to Clara Foods Co., Daly City, CA (US)
Filed by Clara Foods Co., Daly City, CA (US)
Filed on Mar. 22, 2024, as Appl. No. 18/614,611.
Application 18/614,611 is a continuation in part of application No. 18/473,146, filed on Sep. 22, 2023, granted, now 11,974,592, issued on May 7, 2024.
Application 18/473,146 is a continuation of application No. 17/493,067, filed on Oct. 4, 2021, granted, now 11,800,887, issued on Oct. 31, 2023.
Application 17/493,067 is a continuation of application No. 16/986,016, filed on Aug. 5, 2020, granted, now 11,160,299, issued on Nov. 2, 2021.
Application 16/986,016 is a continuation of application No. PCT/US2020/041720, filed on Jul. 10, 2020.
Application 18/614,611 is a continuation in part of application No. 18/045,425, filed on Oct. 10, 2022.
Application 18/045,425 is a continuation of application No. 17/508,064, filed on Oct. 22, 2021.
Application 17/508,064 is a continuation of application No. PCT/US2020/047076, filed on Aug. 19, 2020.
Claims priority of provisional application 62/873,159, filed on Jul. 11, 2019.
Claims priority of provisional application 62/873,154, filed on Jul. 11, 2019.
Claims priority of provisional application 62/888,674, filed on Aug. 19, 2019.
Prior Publication US 2024/0260636 A1, Aug. 8, 2024
Int. Cl. A23L 33/18 (2016.01); A23J 1/18 (2006.01)
CPC A23L 33/18 (2016.08) [A23J 1/18 (2013.01)] 30 Claims
 
1. An ingredient composition for producing a food item, the ingredient composition comprising:
recombinant ovomucoid protein (rOVD); and
one or more additional consumable ingredients;
wherein:
the rOVD comprises at least one glycosylated asparagine residue,
the rOVD is substantially devoid of N-linked mannosylation, and
wherein:
the rOVD is capable of forming a clear liquid at a pH of from about 2.5 to about 6, and/or
the clear liquid comprising the rOVD shows substantially higher liquid clarity as compared to a whey protein fluid at a pH of from about 2 to about 6.